000142989 001__ 142989
000142989 005__ 20240229112538.0
000142989 0247_ $$2doi$$a10.3233/JAD-180593
000142989 0247_ $$2pmid$$apmid:30776005
000142989 0247_ $$2ISSN$$a1387-2877
000142989 0247_ $$2ISSN$$a1875-8908
000142989 037__ $$aDKFZ-2019-00617
000142989 041__ $$aeng
000142989 082__ $$a610
000142989 1001_ $$0P:(DE-HGF)0$$aMöllers, Tobias$$b0$$eFirst author
000142989 245__ $$aFactors Associated with Length of Stay in Hospital Patients with and Without Dementia.
000142989 260__ $$aAmsterdam$$bIOS Press$$c2019
000142989 3367_ $$2DRIVER$$aarticle
000142989 3367_ $$2DataCite$$aOutput Types/Journal article
000142989 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636549347_12226
000142989 3367_ $$2BibTeX$$aARTICLE
000142989 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142989 3367_ $$00$$2EndNote$$aJournal Article
000142989 520__ $$aHospital care of older adults, especially of those with dementia, is associated with a high risk of complications and increased mortality. Adverse events are often triggered by hospital-related factors, hence the time spent in hospitals should be limited. There is little knowledge of the specific factors influencing hospitalizations of older persons.To assess the duration of length of stay (LOS) and risk factors of increased LOS, and, specifically, the role of delirium and neuropsychiatric symptoms (NPS) among a large sample of older adults with and without dementia in Germany.A claims data based dynamic retrospective cohort study from 2004 to 2015 was conducted. People with dementia (PWD) were identified using ICD-10 codes and the application of diagnostic measures. A control group without diagnosis of dementia (CG) were matched in a 3: 1 ratio. Multivariate methods were used to investigate the factors associated with LOS.7,139 PWD and 21,417 controls were included. PWD had longer hospitalizations (first LOS: +4.3 days; second LOS: +0.2 days) than the CG. Diagnosis of delirium was associated with LOS, both for PWD (first LOS: +9.6 days; second LOS: +5.3 days) and CG (first LOS: +13.7 days; second LOS: +7.2 days).Major determinants of LOS were similar in PWD and the CG. The strongest association was found for the presence of delirium and NPS. Future research should focus on prevention and intervention strategies that may reduce the impact of delirium as well as NPS on the length of stay especially for PWD.
000142989 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000142989 588__ $$aDataset connected to CrossRef, PubMed,
000142989 7001_ $$0P:(DE-He78)d9d72431035d8535d1b65ce9a01c2f60$$aPerna, Laura$$b1$$udkfz
000142989 7001_ $$aIhle, Peter$$b2
000142989 7001_ $$aSchubert, Ingrid$$b3
000142989 7001_ $$aBauer, Jürgen$$b4
000142989 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author$$udkfz
000142989 773__ $$0PERI:(DE-600)2070772-1$$a10.3233/JAD-180593$$gVol. 67, no. 3, p. 1055 - 1065$$n3$$p1055 - 1065$$tJournal of Alzheimer's disease$$v67$$x1875-8908$$y2019
000142989 909CO $$ooai:inrepo02.dkfz.de:142989$$pVDB
000142989 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142989 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d9d72431035d8535d1b65ce9a01c2f60$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000142989 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000142989 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000142989 9141_ $$y2019
000142989 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ ALZHEIMERS DIS : 2017
000142989 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142989 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142989 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142989 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000142989 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000142989 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142989 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142989 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142989 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000142989 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000142989 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000142989 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000142989 980__ $$ajournal
000142989 980__ $$aVDB
000142989 980__ $$aI:(DE-He78)C070-20160331
000142989 980__ $$aUNRESTRICTED